B
Beijing Leadman Biochemistry Co Ltd
SZSE:300289
Beijing Leadman Biochemistry Co Ltd
SZSE:300289
Price:
4.7 CNY
1.73%
Market Closed
Updated:
May 16, 2024
Section:
Relative Value
The Relative Value of one Beijing Leadman Biochemistry Co Ltd stock under the Base Case scenario is 2.89 CNY. Compared to the current market price of 4.7 CNY, Beijing Leadman Biochemistry Co Ltd is Overvalued by 39%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
Relative Value
Base Case
2.89
CNY
Overvaluation 39%
B
Valuation Multiples
Multiples Across Competitors
Competitors Multiples
Beijing Leadman Biochemistry Co Ltd Competitors
Beijing Leadman Biochemistry Co Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CN |
B
|
Beijing Leadman Biochemistry Co Ltd
SZSE:300289
|
2.6B CNY | 5.7 | 589.7 | -578.1 | -578.1 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
288.9B USD | 5.3 | 60 | 13 | 19.8 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
168.6B USD | 5.7 | 44.7 | 18.8 | 31 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
113B USD | 11.4 | 31.3 | 25.2 | 26.4 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
106.9B USD | 8.2 | 27.7 | 22.4 | 24.8 | |
| AU |
|
CSL Ltd
ASX:CSL
|
138.6B AUD | 6.6 | 37.6 | 22.6 | 28.1 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
84.5B USD | 3.1 | 174.3 | 7 | 9.2 | |
| US |
|
Moderna Inc
NASDAQ:MRNA
|
50.6B USD | 9.9 | -8.5 | -9.4 | -8.3 | |
| US |
|
Seagen Inc
NASDAQ:SGEN
|
43.1B USD | 18.8 | -57.5 | -61.9 | -55.8 | |
| US |
|
Biogen Inc
NASDAQ:BIIB
|
33.5B USD | 3.4 | 28.6 | 14.6 | 18.2 | |
| KR |
|
Celltrion Inc
KRX:068270
|
40T KRW | 18.4 | 74.7 | 45.7 | 62.9 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
You don't have any saved screeners yet
